x

Search for a clinical trial

* (*) mandatory field

ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma - ES

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Eli lilly and company world headquarters
    • Phase : I - II
  • Principal investigator of clinical trial

  • Dr Nadia HINDI MUÑIZ
  • Unidad de Oncología Médica, Oncología Radioterápica y Radiofísica
  • Hospital Universitario Virgen del Rocío
  • Avenida Manuel Siurot s/n
  • 41013 SEVILLA
  • SPAIN
  • More information
  • Phone  : 34 955 01 22 18
  • Fax  : -
  • Website
  • Principal investigator of clinical trial

  • Dr Claudia VALVERDE
  • Servicio de Oncología médica
  • Hospital Universitari Vall d'Hebron
  • Paseo Vall d'Hebron, 119-129
  • 08035 BARCELONA
  • SPAIN
  • More information
  • Phone  : 34 932746100 ext 6085
  • Fax  : -
  • Website
Last update: May 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.